Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoa...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Jackson, Larry R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: 625: Withdrawn - 2013, AHJ, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:226 ; year:2020 ; pages:85-93 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ahj.2020.04.016 |
|---|
| Katalog-ID: |
ELV05109732X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV05109732X | ||
| 003 | DE-627 | ||
| 005 | 20230624172001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ahj.2020.04.016 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica |
| 035 | |a (DE-627)ELV05109732X | ||
| 035 | |a (ELSEVIER)S0002-8703(20)30124-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Jackson, Larry R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| 264 | 1 | |c 2020 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. | ||
| 700 | 1 | |a Kim, Sunghee |4 oth | |
| 700 | 1 | |a Blanco, Rosalia |4 oth | |
| 700 | 1 | |a Thomas, Laine |4 oth | |
| 700 | 1 | |a Ansell, Jack |4 oth | |
| 700 | 1 | |a Fonarow, Gregg C. |4 oth | |
| 700 | 1 | |a Gersh, Bernard J. |4 oth | |
| 700 | 1 | |a Go, Alan S. |4 oth | |
| 700 | 1 | |a Kowey, Peter R. |4 oth | |
| 700 | 1 | |a Mahaffey, Kenneth W. |4 oth | |
| 700 | 1 | |a Hylek, Elaine M. |4 oth | |
| 700 | 1 | |a Peterson, Eric D. |4 oth | |
| 700 | 1 | |a Piccini, Jonathan P. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |t 625: Withdrawn |d 2013 |d AHJ |g Amsterdam [u.a.] |w (DE-627)ELV011791055 |
| 773 | 1 | 8 | |g volume:226 |g year:2020 |g pages:85-93 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ahj.2020.04.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2020 |h 85-93 |g 9 | ||
| author_variant |
l r j lr lrj |
|---|---|
| matchkey_str |
jacksonlarryrkimsungheeblancorosaliathom:2020----:icniutortsfafrnessietcigrlnioglnsnslnclrcieeutfootoergsrfretrno |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.1016/j.ahj.2020.04.016 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica (DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 DE-627 ger DE-627 rakwb eng 610 VZ 570 VZ BIODIV DE-30 fid Jackson, Larry R. verfasserin aut Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. Kim, Sunghee oth Blanco, Rosalia oth Thomas, Laine oth Ansell, Jack oth Fonarow, Gregg C. oth Gersh, Bernard J. oth Go, Alan S. oth Kowey, Peter R. oth Mahaffey, Kenneth W. oth Hylek, Elaine M. oth Peterson, Eric D. oth Piccini, Jonathan P. oth Enthalten in Elsevier 625: Withdrawn 2013 AHJ Amsterdam [u.a.] (DE-627)ELV011791055 volume:226 year:2020 pages:85-93 extent:9 https://doi.org/10.1016/j.ahj.2020.04.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2020 85-93 9 |
| spelling |
10.1016/j.ahj.2020.04.016 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica (DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 DE-627 ger DE-627 rakwb eng 610 VZ 570 VZ BIODIV DE-30 fid Jackson, Larry R. verfasserin aut Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. Kim, Sunghee oth Blanco, Rosalia oth Thomas, Laine oth Ansell, Jack oth Fonarow, Gregg C. oth Gersh, Bernard J. oth Go, Alan S. oth Kowey, Peter R. oth Mahaffey, Kenneth W. oth Hylek, Elaine M. oth Peterson, Eric D. oth Piccini, Jonathan P. oth Enthalten in Elsevier 625: Withdrawn 2013 AHJ Amsterdam [u.a.] (DE-627)ELV011791055 volume:226 year:2020 pages:85-93 extent:9 https://doi.org/10.1016/j.ahj.2020.04.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2020 85-93 9 |
| allfields_unstemmed |
10.1016/j.ahj.2020.04.016 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica (DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 DE-627 ger DE-627 rakwb eng 610 VZ 570 VZ BIODIV DE-30 fid Jackson, Larry R. verfasserin aut Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. Kim, Sunghee oth Blanco, Rosalia oth Thomas, Laine oth Ansell, Jack oth Fonarow, Gregg C. oth Gersh, Bernard J. oth Go, Alan S. oth Kowey, Peter R. oth Mahaffey, Kenneth W. oth Hylek, Elaine M. oth Peterson, Eric D. oth Piccini, Jonathan P. oth Enthalten in Elsevier 625: Withdrawn 2013 AHJ Amsterdam [u.a.] (DE-627)ELV011791055 volume:226 year:2020 pages:85-93 extent:9 https://doi.org/10.1016/j.ahj.2020.04.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2020 85-93 9 |
| allfieldsGer |
10.1016/j.ahj.2020.04.016 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica (DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 DE-627 ger DE-627 rakwb eng 610 VZ 570 VZ BIODIV DE-30 fid Jackson, Larry R. verfasserin aut Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. Kim, Sunghee oth Blanco, Rosalia oth Thomas, Laine oth Ansell, Jack oth Fonarow, Gregg C. oth Gersh, Bernard J. oth Go, Alan S. oth Kowey, Peter R. oth Mahaffey, Kenneth W. oth Hylek, Elaine M. oth Peterson, Eric D. oth Piccini, Jonathan P. oth Enthalten in Elsevier 625: Withdrawn 2013 AHJ Amsterdam [u.a.] (DE-627)ELV011791055 volume:226 year:2020 pages:85-93 extent:9 https://doi.org/10.1016/j.ahj.2020.04.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2020 85-93 9 |
| allfieldsSound |
10.1016/j.ahj.2020.04.016 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica (DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 DE-627 ger DE-627 rakwb eng 610 VZ 570 VZ BIODIV DE-30 fid Jackson, Larry R. verfasserin aut Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. Kim, Sunghee oth Blanco, Rosalia oth Thomas, Laine oth Ansell, Jack oth Fonarow, Gregg C. oth Gersh, Bernard J. oth Go, Alan S. oth Kowey, Peter R. oth Mahaffey, Kenneth W. oth Hylek, Elaine M. oth Peterson, Eric D. oth Piccini, Jonathan P. oth Enthalten in Elsevier 625: Withdrawn 2013 AHJ Amsterdam [u.a.] (DE-627)ELV011791055 volume:226 year:2020 pages:85-93 extent:9 https://doi.org/10.1016/j.ahj.2020.04.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2020 85-93 9 |
| language |
English |
| source |
Enthalten in 625: Withdrawn Amsterdam [u.a.] volume:226 year:2020 pages:85-93 extent:9 |
| sourceStr |
Enthalten in 625: Withdrawn Amsterdam [u.a.] volume:226 year:2020 pages:85-93 extent:9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
625: Withdrawn |
| authorswithroles_txt_mv |
Jackson, Larry R. @@aut@@ Kim, Sunghee @@oth@@ Blanco, Rosalia @@oth@@ Thomas, Laine @@oth@@ Ansell, Jack @@oth@@ Fonarow, Gregg C. @@oth@@ Gersh, Bernard J. @@oth@@ Go, Alan S. @@oth@@ Kowey, Peter R. @@oth@@ Mahaffey, Kenneth W. @@oth@@ Hylek, Elaine M. @@oth@@ Peterson, Eric D. @@oth@@ Piccini, Jonathan P. @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011791055 |
| dewey-sort |
3610 |
| id |
ELV05109732X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05109732X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624172001.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ahj.2020.04.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05109732X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-8703(20)30124-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jackson, Larry R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Sunghee</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blanco, Rosalia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas, Laine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ansell, Jack</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fonarow, Gregg C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gersh, Bernard J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Go, Alan S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kowey, Peter R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahaffey, Kenneth W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hylek, Elaine M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peterson, Eric D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Piccini, Jonathan P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">625: Withdrawn</subfield><subfield code="d">2013</subfield><subfield code="d">AHJ</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011791055</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:226</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:85-93</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ahj.2020.04.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">226</subfield><subfield code="j">2020</subfield><subfield code="h">85-93</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| author |
Jackson, Larry R. |
| spellingShingle |
Jackson, Larry R. ddc 610 ddc 570 fid BIODIV Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| authorStr |
Jackson, Larry R. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011791055 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 570 VZ BIODIV DE-30 fid Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| topic |
ddc 610 ddc 570 fid BIODIV |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV |
| topic_browse |
ddc 610 ddc 570 fid BIODIV |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s k sk r b rb l t lt j a ja g c f gc gcf b j g bj bjg a s g as asg p r k pr prk k w m kw kwm e m h em emh e d p ed edp j p p jp jpp |
| hierarchy_parent_title |
625: Withdrawn |
| hierarchy_parent_id |
ELV011791055 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
625: Withdrawn |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011791055 |
| title |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| ctrlnum |
(DE-627)ELV05109732X (ELSEVIER)S0002-8703(20)30124-1 |
| title_full |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| author_sort |
Jackson, Larry R. |
| journal |
625: Withdrawn |
| journalStr |
625: Withdrawn |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
85 |
| author_browse |
Jackson, Larry R. |
| container_volume |
226 |
| physical |
9 |
| class |
610 VZ 570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Jackson, Larry R. |
| doi_str_mv |
10.1016/j.ahj.2020.04.016 |
| dewey-full |
610 570 |
| title_sort |
discontinuation rates of warfarin versus direct acting oral anticoagulants in us clinical practice: results from outcomes registry for better informed treatment of atrial fibrillation ii (orbit-af ii) |
| title_auth |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| abstract |
While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. |
| abstractGer |
While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. |
| abstract_unstemmed |
While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| title_short |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) |
| url |
https://doi.org/10.1016/j.ahj.2020.04.016 |
| remote_bool |
true |
| author2 |
Kim, Sunghee Blanco, Rosalia Thomas, Laine Ansell, Jack Fonarow, Gregg C. Gersh, Bernard J. Go, Alan S. Kowey, Peter R. Mahaffey, Kenneth W. Hylek, Elaine M. Peterson, Eric D. Piccini, Jonathan P. |
| author2Str |
Kim, Sunghee Blanco, Rosalia Thomas, Laine Ansell, Jack Fonarow, Gregg C. Gersh, Bernard J. Go, Alan S. Kowey, Peter R. Mahaffey, Kenneth W. Hylek, Elaine M. Peterson, Eric D. Piccini, Jonathan P. |
| ppnlink |
ELV011791055 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ahj.2020.04.016 |
| up_date |
2024-07-06T19:19:27.320Z |
| _version_ |
1803858547648233472 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05109732X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624172001.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ahj.2020.04.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001107.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05109732X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-8703(20)30124-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jackson, Larry R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">While oral anticoagulation is a cornerstone of stroke prevention therapy in atrial fibrillation (AF), few studies have evaluated comparative discontinuation rates in clinical practice. The objective of this study is to evaluate discontinuation rates among patients on warfarin and direct oral anticoagulants (DOACs) in clinical practice.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Sunghee</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blanco, Rosalia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas, Laine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ansell, Jack</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fonarow, Gregg C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gersh, Bernard J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Go, Alan S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kowey, Peter R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahaffey, Kenneth W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hylek, Elaine M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peterson, Eric D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Piccini, Jonathan P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">625: Withdrawn</subfield><subfield code="d">2013</subfield><subfield code="d">AHJ</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011791055</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:226</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:85-93</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ahj.2020.04.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">226</subfield><subfield code="j">2020</subfield><subfield code="h">85-93</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
| score |
7.398164 |